Liquid Biopsy in Oligometastatic Prostate Cancer-A Biologist's Point of View.
Ontology highlight
ABSTRACT: Prostate cancer (PCa) is the main cause of cancer-related mortality in males and the diagnosis, treatment, and care of these patients places a great burden on healthcare systems globally. Clinically, PCa is highly heterogeneous, ranging from indolent tumors to highly aggressive disease. In many cases treatment-generally either radiotherapy (RT) or surgery-can be curative. Several key genetic and demographic factors such as age, family history, genetic susceptibility, and race are associated with a high incidence of PCa. While our understanding of PCa, which is mainly based on the tools of molecular biology-has improved dramatically in recent years, efforts to better understand this complex disease have led to the identification of a new type of PCa-oligometastatic PCa. Oligometastatic dise
SUBMITTER: Stelcer E
PROVIDER: S-EPMC6702517 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA